hesperidin has been researched along with Parkinson Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Afolayan, O; Faniyan, O; Ishola, IO; O Adeyemi, O; O Odutola, I | 1 |
| Araujo, SM; Bortolotto, VC; Janner, DE; La Rosa Novo, D; Meichtry, LB; Mesko, MF; Musachio, EAS; Poetini, MR; Prigol, M; Ramborger, BP; Roehrs, R; Silva, NC | 1 |
| Cui, Z; Li, L; Liu, F; Lu, F; Qu, L; Wang, W | 1 |
| Elyasi, L; Hamid Abadi, HG; Jahanshahi, M; Jameie, M; Jameie, SB; Khalili, M; Nikmahzar, E | 1 |
| Braidy, N; Essa, MM; Guillemin, GJ; Karthikeyan, S; Manivasagam, T; Prasad, NR; Selvaraju, S; Tamilselvam, K; Thenmozhi, AJ | 1 |
| Baluchnejadmojarad, T; Khalili, M; Kiasalari, Z; Roghani, M | 1 |
6 other study(ies) available for hesperidin and Parkinson Disease
| Article | Year |
|---|---|
Therapeutic potential of hesperidin in Parkinson's disease with dementia: inhibition of alpha synuclein and amyloid beta in Drosophila melanogaster.
Topics: alpha-Synuclein; Amyloid beta-Peptides; Animals; Dementia; Drosophila melanogaster; Hesperidin; Parkinson Disease | 2021 |
Improvement of non-motor and motor behavioral alterations associated with Parkinson-like disease in Drosophila melanogaster: Comparative effects of treatments with hesperidin and L-dopa.
Topics: Animals; Disease Models, Animal; Dopamine; Drosophila melanogaster; Hesperidin; Levodopa; Parkinson Disease | 2022 |
Citrus Flavonoid Hesperetin Inhibits α-Synuclein Fibrillogenesis, Disrupts Mature Fibrils, and Reduces Their Cytotoxicity: In Vitro and In Vivo Studies.
Topics: alpha-Synuclein; Amyloid; Flavonoids; Hesperidin; Humans; Parkinson Disease | 2023 |
6-OHDA mediated neurotoxicity in SH-SY5Y cellular model of Parkinson disease suppressed by pretreatment with hesperidin through activating L-type calcium channels.
Topics: Apoptosis; Calcium; Calcium Channels, L-Type; Cell Line, Tumor; Cell Survival; Hesperidin; Humans; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Reactive Oxygen Species | 2020 |
Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson's disease.
Topics: Adenosine Triphosphate; Apoptosis; bcl-2-Associated X Protein; Biomarkers; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Hesperidin; Humans; Membrane Potential, Mitochondrial; Models, Biological; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species; Rotenone | 2013 |
Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat.
Topics: Administration, Oral; Animals; Apoptosis; Corpus Striatum; Glial Fibrillary Acidic Protein; Gliosis; Hesperidin; Male; Neuroprotective Agents; NF-kappa B; Oxidative Stress; Oxidopamine; Parkinson Disease; Rats, Wistar | 2016 |